Immune checkpoint genes, chemokines, chemokine receptors, and MHC in the majority of tumors were positively associated with FADS2, while negatively correlated in TGCT, ACC, GBM, GBMLGG, LGG, CESC, and SARC (Fig. 7A). This evidence concerns the gene HLA-C and glioblastoma.